Subcutaneous Immunoglobulin for Maintenance Treatment in Chronic Inflammatory Demyelinating Polyneuropathy - A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial: The PATH Study

Muscle and Nerve - United States
doi 10.1002/mus.25768
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Wiley